Bone Marrow TransplantationBone MarrowBone Marrow CellsLeukemiaTransplantation, HomologousBone and BonesGraft vs Host DiseaseLeukemia, Myeloid, AcuteWhole-Body IrradiationTransplantation, AutologousValerianLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTissue DonorsHematopoietic Stem CellsCytomegalovirus InfectionsHematopoietic Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibility TestingTransplantation ConditioningBone Marrow DiseasesGraft SurvivalBone RemodelingBone Marrow ExaminationImmunosuppressive AgentsHematologic NeoplasmsBone Marrow PurgingLeukemia, LymphoidImmunocompromised HostHistocompatibilityBone Marrow NeoplasmsOpportunistic InfectionsTime FactorsLeukemia, Lymphocytic, Chronic, B-CellImmunosuppressionHematopoiesisTransplantation ChimeraMice, Inbred C57BLRecurrenceTreatment OutcomeAcute DiseaseCyclosporineGraft RejectionBone DensityMycosesLeukemia, ExperimentalBusulfanRetrospective StudiesRadiation ChimeraKidney TransplantationCytomegalovirusFatal OutcomeColony-Forming Units AssayBone ResorptionCyclophosphamideHematologic DiseasesTransplantation, IsogeneicSurvival AnalysisCell DifferentiationT-LymphocytesPneumonia, ViralHLA AntigensNuclear FamilyCombined Modality TherapyRemission InductionLymphocyte DepletionGanciclovirGraft vs Host ReactionPolymerase Chain ReactionFlow CytometryMyelodysplastic SyndromesLeukemia, MyeloidLymphoma, Non-HodgkinHepatic Veno-Occlusive DiseaseCells, CulturedBone NeoplasmsCystitisBlood Group IncompatibilityLeukocyte CountMucormycosisTransplantsLeukemia Virus, MurineSurvival RateLymphocyte TransfusionAntigens, CD34Disease-Free SurvivalSpleenAntilymphocyte SerumGranulocytesChimeraBone DevelopmentFollow-Up StudiesLeukemia, Myeloid, Accelerated PhaseMice, Inbred BALB CBone DiseasesMultiple MyelomaBlood CellsMethotrexateInfectionNeutropeniaAntineoplastic Combined Chemotherapy Protocols